Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | PPARD | Q03181 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5963227 | 1.00 | TSHR (0.62) | TSHRTP53TDP1CYP3A4PPARD | |
| SCHEMBL15301352 | 0.90 | TSHR (0.50) | TSHRTP53TDP1CYP3A4CA12 | |
| SCHEMBL2699600 | 0.89 | TSHR (0.48) | TSHRTP53TDP1PPARDSMN1; SMN2 | |
| SCHEMBL16924875 | 0.89 | TSHR (0.48) | TSHRTP53TDP1PPARDSMN1; SMN2 | |
| SCHEMBL17877993 | 0.88 | TSHR (0.48) | TSHRTP53TDP1 | |
| SCHEMBL575208 | 0.87 | SMN1; SMN2 (0.38) | TSHRCYP3A4SMN1; SMN2CA1CA2 | |
| SCHEMBL2122687 | 0.87 | TSHR (0.46) | TSHRTP53TDP1MEN1KMT2A | |
| SCHEMBL15301316 | 0.87 | CYP3A4 (0.61) | TSHRCYP3A4 | |
| SCHEMBL7262046 | 0.82 | CYP3A4 (0.48) | TSHRCYP3A4SMN1; SMN2MEN1GAA | |
| SCHEMBL5963931 | 0.82 | CYP3A4 (0.48) | TSHRCYP3A4SMN1; SMN2MEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260149031-A1 | LITHIUM-ION BATTERY | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2026-05-28 | — | — | US | claimed |
| US-20260149055-A1 | LITHIUM-ION BATTERY | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2026-05-28 | — | — | US | claimed |
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | Anthro Energy, Inc. (US) | 2026-03-26 | — | — | US | claimed |
| US-12494515-B1 | Lithium-ion battery | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2025-12-09 | — | — | US | claimed |
| US-20250329799-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY | Anthro Energy, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| US-20250149631-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2025-05-08 | — | — | US | claimed |
| WO-2025081765-A1 | POSITIVE ELECTRODE SHEET, SECONDARY BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2025-04-24 | — | — | WO | claimed |
| WO-2024235033-A1 | SECONDARY BATTERY AND DEVICE | 蔚来汽车科技(安徽)有限公司 | 2024-11-21 | — | — | WO | claimed |
| WO-2024217459-A1 | SECONDARY BATTERY AND APPARATUS | 蔚来汽车科技(安徽)有限公司 | 2024-10-24 | — | — | WO | claimed |
| US-20170309958-A1 | ELECTROLYTIC SOLUTION FOR SODIUM-ION SECONDARY BATTERY AND SODIUM-ION SECONDARY BATTERY | SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) | 2017-10-26 | — | — | US | claimed |
| US-20150011773-A1 | RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING | PIRAMAL IMAGING SA (CH) | 2015-01-08 | — | — | US | claimed |
| US-20260149055-A1 | LITHIUM-ION BATTERY | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2026-05-28 | — | — | US | disclosed |
| US-20260149031-A1 | LITHIUM-ION BATTERY | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2026-05-28 | — | — | US | disclosed |
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | Anthro Energy, Inc. (US) | 2026-03-26 | — | — | US | disclosed |
| US-12494515-B1 | Lithium-ion battery | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2025-12-09 | — | — | US | disclosed |
| EP-2144321-A1 | NONAQUEOUS ELECTROLYTE FOR RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-01-13 | — | — | EP | disclosed |
| EP-0825664-B1 | Non-aqueous electrolytic solutions and non-aqueous electrolyte cells comprising the same | MITSUI CHEMICALS INC (JP) | 2003-10-08 | — | — | EP | disclosed |
| EP-0825664-A1 | Non-aqueous electrolytic solutions and non-aqueous electrolyte cells comprising the same | Mitsui Chemicals, Inc. (JP) | 1998-02-25 | — | — | EP | disclosed |
| US-5580684-A | PHOSPHORIC ACID ESTER SOLVENT FOR LITHIUM SALT ELECTROLYTE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-03 | — | — | US | disclosed |
| EP-0696077-A2 | Non-aqueous electrolyte solutions and secondary cells comprising the same | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1996-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011773-A1 | RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING | SLC1A5, SLC6A19, BCAT2 | TSHR 1460/4885TP53 360/4885TDP1 3981/4885 |
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | FTO, DCX, TET1 | TSHR 1842/4885TP53 2179/4885TDP1 234/4885 |
| US-20260149031-A1 | LITHIUM-ION BATTERY | SLC9A2, SLC9A1, CACNA2D1 | TSHR 1310/4885TP53 1844/4885TDP1 2614/4885 |
| US-20260149055-A1 | LITHIUM-ION BATTERY | LEF1, SLC9A2, CACNA2D1 | TSHR 1150/4885TP53 1155/4885TDP1 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.